In line with existing literature (Hanel and Moll, 2012), TP53-d is associated with a significantly increased number of SVs across the genome (Wilcoxon rank-sum test; Figure 4h, i), except in skin cancers. This evidence concerns the gene TP53 and skin neoplasm.